
Damita M 5/1000 Tablet ER
Marketer
Macleods Pharmaceuticals Pvt Ltd
Salt Composition
Dapagliflozin (5mg) + Metformin (1000mg)
Overview Damita M 5/1000 Tablet ER
Diabetic patients with type 2 mellitus may find relief with the extended-release Damita M 5/1000 tablet, a dual-medication formulation. This treatment effectively manages elevated blood glucose, mitigating the risk of severe diabetic complications and potentially cardiovascular issues. Consumption with food is recommended, maintaining a consistent daily schedule to aid adherence. Dosage is determined by your physician; discontinuation requires their consultation, as abrupt cessation can elevate blood sugar, increasing vulnerability to complications like renal impairment and vision loss. This medication is a component of a comprehensive program incorporating a healthy diet, exercise, and weight management, guided by your doctor's recommendations. Commonly reported side effects encompass throat irritation, nasal congestion, rhinorrhea, cephalalgia, nausea, emesis, and diarrhea. Hydration is crucial to prevent dehydration. Genital fungal infections are a possibility; diligent hygiene can help minimize this risk. Prior to commencing treatment, disclose any pre-existing renal or hepatic conditions, urinary tract infections, or diuretic use to your doctor. Pregnant or lactating individuals should seek medical counsel before initiating use. Excessive alcohol should be avoided, as it could intensify certain side effects. Regular blood glucose monitoring is advised throughout treatment.
Uses of Damita M 5/1000 Tablet ER
Managing type 2 diabetes
Major Benefits of Damita M 5/1000 Tablet ER:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or breaking it. The Damita M 5/1000 Extended-Release tablet should be taken with a meal.
Common Side effects of Damita M 5/1000 Tablet ER:
- Nausea
- Vomiting
- Diarrhea
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
- Polyuria
- Flatulence
- Skin rash
- Taste change
- Difficulty in urination
- Hypoglycemia (low blood glucose level)
- Tremors
- Dizziness
- Back pain
- Increased hematocrit
- Decreased creatinine clearance
- Dyslipidemia
How to use Damita M 5/1000 Tablet ER:
Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the Damita M 5/1000 Tablet ER whole; avoid chewing, crushing, or fracturing. Consume with food.
How Damita M 5/1000 Tablet ER works:
Damita M 5/1000 Extended-Release tablets combine dapagliflozin and metformin to manage type 2 diabetes. Dapagliflozin facilitates glucose excretion via the kidneys, while metformin reduces hepatic glucose output, slows intestinal glucose uptake, and enhances insulin responsiveness. This dual action optimizes blood glucose regulation.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use and Damita M 5/1000 Tablet ER is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The extended-release Damita M 5/1000 Tablet may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to the fetus. Your physician will assess the potential benefits against any risks prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Damita M 5/1000 Tablet is likely unsuitable for breastfeeding mothers. Available human data indicate potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving may be impaired if your blood glucose level is abnormally low or elevated. Refrain from driving should these conditions arise.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Damita M 5/1000 ER tablets. Dosage modification of Damita M 5/1000 ER tablets may be necessary; physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Damita M 5/1000 Extended-Release tablets cautiously. Dosage modification of Damita M 5/1000 Extended-Release tablets may be necessary. Physician consultation is advised.
What if you forget to take Damita M 5/1000 Tablet ER :
Should you forget a Damita M 5/1000 Tablet ER dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Damita M 5/1000 Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
